Aptahem AB (STU:94V) E10: €-4.23 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:94V Aptahem AB STU:94V
30 GF Score
Price €0.07
! 2 Warning Signs
View Full Analysis

What is Aptahem AB E10?

Aptahem AB STU:94V 30 E10 is €-4.23 as of Mar. 2026. GuruFocus rates STU:94V with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Aptahem AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-4.23 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-15), Aptahem AB's current stock price is €0.07071. Aptahem AB's E10 for the quarter that ended in Mar. 2026 was €-4.23. Aptahem AB's Shiller PE Ratio of today is .


Aptahem AB  (STU:94V) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Aptahem AB E10 Related Terms


Aptahem AB E10 Historical Data

* Premium members only.

The historical data trend for Aptahem AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptahem AB E10 Chart

Aptahem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.18 -2.94

Aptahem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.27 -3.27 -3.03 -2.94 -4.23

STU:94V vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Aptahem AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptahem AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptahem AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aptahem AB's Shiller PE Ratio falls into.


STU:94V
30GF Score
Aptahem AB STU:94V
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptahem AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aptahem AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/133.5600*133.5600
=0.000

Current CPI (Mar. 2026) = 133.5600.

Aptahem AB Quarterly Data

per share eps CPI Adj_EPS
201606 -2.837 101.019 -3.751
201609 -1.563 101.138 -2.064
201612 -1.808 102.022 -2.367
201703 -1.449 102.022 -1.897
201706 -2.774 102.752 -3.606
201709 -1.266 103.279 -1.637
201712 -1.044 103.793 -1.343
201803 -1.301 103.962 -1.671
201806 -3.984 104.875 -5.074
201809 -1.584 105.679 -2.002
201812 -1.553 105.912 -1.958
201903 -0.503 105.886 -0.634
201906 -0.684 106.742 -0.856
201909 -0.803 107.214 -1.000
201912 -0.470 107.766 -0.582
202003 -0.382 106.563 -0.479
202006 -0.528 107.498 -0.656
202009 -0.615 107.635 -0.763
202012 -1.374 108.296 -1.695
202103 -1.262 108.360 -1.555
202106 -0.423 108.928 -0.519
202109 -0.280 110.338 -0.339
202112 -0.373 112.486 -0.443
202203 -0.108 114.825 -0.126
202206 -0.069 118.384 -0.078
202209 -0.068 122.296 -0.074
202212 -0.123 126.365 -0.130
202303 -0.121 127.042 -0.127
202306 -0.156 129.407 -0.161
202309 -0.001 130.224 -0.001
202312 -0.002 131.912 -0.002
202403 -0.001 132.205 -0.001
202406 -0.039 132.716 -0.039
202409 -0.018 132.304 -0.018
202412 -0.019 132.987 -0.019
202503 -0.015 132.825 -0.015
202506 -0.007 133.699 -0.007
202509 -0.007 133.480 -0.007
202512 -0.007 133.390 -0.007
202603 0.000 133.560 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-4.23 mean?
Aptahem AB (STU:94V) has a E10 of €-4.23 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Aptahem AB and its competitors.
Is Aptahem AB's E10 too high?
Aptahem AB's current E10 is €-4.23. Overall, Aptahem AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Aptahem AB's E10 compare to VRTX and REGN?
Aptahem AB's E10 of €-4.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Aptahem AB and its competitors. Aptahem AB's current E10 is €-4.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptahem AB stock overvalued right now?
Aptahem AB (STU:94V) has a current E10 of €-4.23. The current E10 is €-4.23. Aptahem AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Aptahem AB (STU:94V), the current E10 is €-4.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptahem AB Business Description

Other Exchanges APTA:Sweden
Address Norra Vallgatan 58, Malmo, SWE, 211 22
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
30GF Score

Get the complete analysis for STU:94V

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price